Efficacy and tolerance of topical calcitriol 3 μg g-1 in psoriasis treatment: A review of our experience in Poland

British Journal of Dermatology, Supplement

Volumn 144, Issue 58, 2001, Pages 11-16

  Langner, A ^a   Stapor W ^a   Ambroziak, M ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Spa Dermatological Clinic ^*  (Poland)

Author keywords

Betamethasone valerate; Calcitriol; Efficacy; Psoriasis; Safety

Indexed keywords

BETAMETHASONE VALERATE; CALCITRIOL; PETROLATUM; SILKIS OINTMENT;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCALCIURIA; MALE; POLAND; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; TOPICAL TREATMENT;

EID: 0035029902     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.00040.x     Document Type: Conference Paper

References (11)

1. 25-Hydro-xycholecalciferol UV therapy in psoriasis
2. 3 increases intracellular calcium in human keratinocytes
3. A patient with psoriasis cured by 1-alpha-hydroxyvitamin D3
4. 3 treatment in psoriasis vulgaris
5. 3. A review of our experience
6. 3 can be a safe and effective therapy for psoriasis
7. 3 is a novel, safe, effective therapy for the treatment of psoriasis: A three-year experience and histologic analysis
8. 3 in dermatology: A critical appraisal
9. 3 (calcitriol) ointment in psoriasis
10. Topical calcitriol in the treatment of chronic plaque psoriasis: A double-blind study
11. Reproducibility of clinical trials of topical glucocorticosteroids